Cerebrospinal fluid and blood exosomes as biomarkers for amyotrophic lateral sclerosis; a systematic review
Abstract Background Amyotrophic lateral sclerosis (ALS) is a progressive and fatal motor neuron disease. Due to the limited knowledge about potential biomarkers that help in early diagnosis and monitoring disease progression, today’s diagnoses are based on ruling out other diseases, neurography, and...
Main Authors: | Shahram Darabi, Armin Ariaei, Auob Rustamzadeh, Dariush Afshari, Enam Alhagh Charkhat Gorgich, Leila Darabi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-03-01
|
Series: | Diagnostic Pathology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13000-024-01473-6 |
Similar Items
-
Which neuroimaging and fluid biomarkers method is better in theranostic of Alzheimer’s disease? An umbrella review
by: Hossein Mohammadi, et al.
Published: (2024-06-01) -
Extracellular Vesicles in Amyotrophic Lateral Sclerosis
by: Gavin McCluskey, et al.
Published: (2022-12-01) -
Exosome microRNAs in Amyotrophic Lateral Sclerosis: A Pilot Study
by: Francesca Pregnolato, et al.
Published: (2021-08-01) -
Pathological Proteins Are Transported by Extracellular Vesicles of Sporadic Amyotrophic Lateral Sclerosis Patients
by: Daisy Sproviero, et al.
Published: (2018-07-01) -
Extracellular Vesicles as Innovative Treatment Strategy for Amyotrophic Lateral Sclerosis
by: Ke Wang, et al.
Published: (2021-11-01)